We have studied the action of various antimicrobial agents in microbiological media and in human duodenopancreatic secretions. In the latter medium, clioquinol exhibited a rapid bactericidal effect on both growing and stationary bacteria at concentrations near its MIC. However, it was merely bacteriostatic in microbiological media, even at high concentrations. Phanquinone, chlorquinaldol, and, to a lesser extent, also chloramphenicol and trimethoprim likewise displayed enhanced bactericidal activity in duodeno-pancreatic secretions, but various other antibacterial agents did not. These findings suggest that duodeno-pancreatic secretions contain a factor augmenting the antibacterial activity of a number of drugs.
Clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) is an antimicrobial agent used to treat protozoal and bacterial infections of the intestinal tract (2, 9). In the usual microbiological media, its activity against gram-negative bacteria is relatively weak (7, 8) . We have, therefore, studied its action under more physiological conditions, i.e., in human duodenopancreatic secretions, which represent the natural environment for drugs used in therapy of enteric infections, and found its activity to be greatly enhanced. Similar observations were made with several other antibiotics, indicating the presence in duodeno-pancreatic secretions of an activity that augments the bactericidal activity of certain antimicrobial agents.
MATERIALS AND METHODS Human duodeno-pancreatic secretions. Human duodenopancreatic secretions were collected after stimulation of pancreatic and biliary secretion with synthetic secretin (Roche; 1 clinical unit per kg) and natural cholecystokinin (Kabi; 1 ivy dog unit per kg) from healthy volunteers aged 20 to 35 years who were not undergoing medical treatment and who had no history of gastrointestinal disease, after overnight fasting, by aspiration through an Eynard double-lumen tube whose position was controlled radiologically. The contents of bicarbonate, protein, and amylase of the duodenopancreatic secretions were within normal limits (1). Samples were stored at -20°C. Before use, samples of duodenopancreatic secretions were sterilized by filtration (0.22-pum pore size; Millipore filters) and adjusted with 1 N HCl to pH 7.6, approximately the pH of native duodeno-pancreatic secretions (4).
Bacterial strains. The bacterial strains used in this study were from the Ciba-Geigy culture collection (7), with stocks being kept in the gas phase of liquid nitrogen. The strains are listed in Table 1 Table 2 ). The proteins were from Sigma Chemical Co., St. Louis, Mo.
MIC. Clioquinol was dissolved in dimethyl sulfoxide and diluted 100-fold into the first of the dilution tubes. MICs were determined by serial two-fold dilution of the antibiotic in medium (0.5 ml each), inoculation with 105 CFU/ml, and incubation for 20 h at 37°C. Viable bacteria were then quantitated by plating on BHI agar. Since aqueous solutions containing more than 10 ,ug of clioquinol per ml remained visibly turbid, the MIC was defined as the lowest concentration preventing bacterial growth (<106 CFU/ml after 20 h of incubation; controls in minimal medium or duodeno-pancreatic secretions without antibiotics yielded >108 CFU/ml).
MBC was defined as the lowest concentration reducing the viability at least 1,000-fold (<102 CFU/ml). MICs and MBCs were also determined in minimal media supplemented with one of the following reagents: bile salts (5 mg/ml; Merck, Darmstadt, Federal Republic of Germany), lysozyme (100 ,ug/ml; Serva, Heidelberg, Federal Republic of Germany), trypsin (420 ,ug/ml; Serva), and chymotrypsin (420 p.g/ml; Serva). The influence of the pH of minimal medium on MICs and MBCs was examined by adjustment of the pH to the desired value with HCl or NaOH (between 6.5 and 8.0; the pH of untreated minimal medium was 7.1).
Antibacterial agents. The antibacterial agents were from Ciba-Geigy (bicozamycin [6] , chlorquinaldol [5,7- M9 and then sedimented and suspended to their initial volume with duodeno-pancreatic secretions. The suspension was divided into four equal portions, to which clioquinol was added from 100-fold-concentrated stock solutions made up in dimethyl sulfoxide, to give final concentrations of 0.5 (0), 4 (A), and 10 (A) Fg/ml. One portion contained only dimethyl sulfoxide (0). Samples were taken after various times of incubation at 37°C for determination of viable bacteria. 36 METT ET AL.
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The activity of duodeno-pancreatic secretions augmenting the antibacterial action of certain drugs appeared to be of low molecular weight, since it could be dialyzed through membranes with a nominal molecular weight cutoff of 5,000 (Diachema AG, Ruschlikon, Switzerland).
The fact that duodeno-pancreatic secretions also enhance the bactericidal activity of structurally unrelated compounds suggests that either they have a general effect on bacterial susceptibility to some agents or the antibacterial agents sensitize the bacteria to a bactericidal activity present in duodeno-pancreatic secretions. Previous exposure of bacteria to duodeno-pancreatic secretions did not render them more susceptible to the bactericidal action of clioquinol alone (Fig. 2) . Conversely, successive incubation of bacteria in minimal medium containing clioquinol and then in clioquinol-free duodeno-pancreatic secretions also did not result in bacterial death (data not shown). Under our conditions, bacterial killing was observed only in the simultaneous presence of clioquinol and duodeno-pancreatic secretions.
DISCUSSION
The antibacterial activity of clioquinol was found to be highly dependent on the bacterial growth medium. The differences in the MICs of clioquinol seen in various media (Tables 1 and 2 ) may be due to interactions with proteins, metal salts, and possibly also other constituents. However, we can as yet offer no explanation for the bactericidal activity of clioquinol in duodeno-pancreatic secretions, whereas it is only bacteriostatic in other media. This effect could not be reproduced in minimal medium by supplementing it with constituents of duodeno-pancreatic secretions such as bile salts, lysozyme, trypsin, or chymotrypsin or by varying its pH between 6.5 and 8.0 (data not shown).
The lack of effect of iron in duodeno-pancreatic secretions (Table 2 ) may be due to the presence of endogenous iron already exerting maximal antagonism against clioquinol. Clioquinol is known to form complexes with proteins (3) and metal ions (5), with the complexes apparently being less active against bacteria than the free drug.
Clioquinol exerted bactericidal activity only when administered simultaneously with duodeno-pancreatic secretions ( Fig. 1 and 2) . Preincubation of bacteria in duodeno-pancreatic secretions did not sensitize them to a bactericidal effect of subsequent incubation in minimal medium containing clioquinol. Bacterial survival in duodeno-pancreatic secre- for 48 h in M9 medium (AL, A) or duodeno-pancreatic secretions (0, 0) without cloquinol. Each culture was then divided into two equal portions and sedimented. One portion was suspended in fresh M9 medium containing 2 pug of clioquinol per ml (open symbols); the other was suspended in duodeno-pancreatic secretions containing 2 ,ug of clioquinol per ml (closed symbols). After various times of further incubation at 37°C, samples were assayed for viable bacteria.
tions was not significantly affected upon preincubation in minimal medium containing clioquinol (data not shown). The cooperative bactericidal action of duodeno-pancreatic secretions was not restricted to clioquinol but was also found in combination with several other antimicrobial agents (Table  3) .
The data presented show that antibacterial agents may exhibit quite different and unexpected activities when they are tested under conditions similar to those prevailing in vivo. Duodeno-pancreatic secretions seem to contain a factor which enhances the bactericidal activity of clioquinol and certain other drugs. This activity was not inactivated by heat treatment and was of a low-molecular-weight nature (data not shown); it is, therefore, different from the known antibacterial constituents of body fluids such as complement components or serum lysozyme.
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